Healthy volunteers help pick best pill form for new drug
NCT ID NCT07240116
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study enrolled 18 healthy adults to compare how the body absorbs miricorilant from different tablet types. Participants received the drug in various forms and doses on separate days. The goal is to find which formulation works best for future trials. This is an early-stage study focused on drug behavior, not treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Miricorilant
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site 01
Miami, Florida, 33126, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test